Investment Summary

Warburg Pincus Invests In Silk Road Medical

On April 1, 2011, private equity firm Warburg Pincus invested in medical products company Silk Road Medical

Investment Highlights
  • This is Warburg Pincus’ 15th transaction in the Medical Products sector.
  • This is Warburg Pincus’ 103rd transaction in the United States.
  • This is Warburg Pincus’ 23rd transaction in California.
Investment Fate
  • Silk Road Medical went public in 2019.
  • Silk Road Medical was sold to a strategic buyer in 2024 for 1.3B USD.

Investment Summary

Date 2011-04-01
Target Silk Road Medical
Sector Medical Products
Investor(s) Warburg Pincus
Deal Type Venture

Target

Silk Road Medical

Sunnyvale, California, United States
Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Silk Road Medial was formed in 2007 and is based in Sunnyvale, California.

Search 206,010 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.


DEAL STATS #
Overall 189 of 485
Sector: Medical Products M&A 15 of 21
Type: M&A Deals 29 of 70
State: California M&A 23 of 46
Country: United States M&A 103 of 238
Year: 2011 M&A 6 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-23 Sotera Health

Broadview Heights, Ohio, United States

Sotera Health, along with its business entities, provides an integrated protector of global health, providing mission-critical services to the medical device, pharmaceutical, tissue, and food industries. Sotera Health operates 61 facilities in 13 countries. Sotera Health serves more than 5,000 customers worldwide, including 75 of the top 100 medical device manufacturers. Sotera Health was formed in 2015 and is based in Broadview Heights, Ohio.

Buy $675M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-12 Black Swan Energy

Calgary, Alberta, Canada

Black Swan Energy is an energy company that is actively developing its significant land position in the Montney play in northeast British Columbia. Black Swan Energy was founded in 2010 and is based in Calgary, Alberta.

Buy -